Skip to Main Content

INFORMATION FOR

    Kelly Cosgrove, PhD

    Professor of Psychiatry and of Neuroscience and of Radiology and Biomedical Imaging
    DownloadHi-Res Photo

    Additional Titles

    Co-Director of the T32 Translational Alcohol Research Program, Psychiatry and Public Health

    Contact Info

    Psychiatry

    40 Temple

    New Haven, CT 06511-

    United States

    About

    Titles

    Professor of Psychiatry and of Neuroscience and of Radiology and Biomedical Imaging

    Co-Director of the T32 Translational Alcohol Research Program, Psychiatry and Public Health

    Biography

    Dr. Cosgrove uses neuroreceptor imaging techniques such as PET to gain insights into the brains of people with substance use and other stress-related disorders. Trained as a clinical psychologist who worked with individuals managing alcohol and drug use disorders, Dr. Cosgrove transitioned to conducting research in order to inform the treatment of substance use disorders. Her laboratory develops and applies innovative brain imaging paradigms to track changes in critical neurochemicals over time, to identify treatment targets for psychiatric disorders, and to examine individual and sex and gender differences.

    Appointments

    Education & Training

    Psychology Intern
    Medical University of South Carolina (2003)
    PhD
    University of Minnesota (2002)
    BS
    University of Minnesota (1997)

    Research

    Overview

    1. Examining effects of chronic alcohol consumption on the neuroimmune system and relationships to synaptic plasticity in living humans with alcohol use disorder. In addition, examining the mu and kappa opioid receptor systems and relationship to clinical outcomes in people with alcohol use disorder.
    2. Examining the stress and neuroimmune systems with PET and the application to psychiatric disorders such as PTSD.
    3. Radiotracer development targeted at the stress and neuroimmune systems.
    4. Examination of sex differences in the dopaminergic signature of smoking- and nicotine-induced dopamine release using novel PET brain imaging techniques.
    5. Understanding the functional basis and behavioral and cognitive correlates of the changes in beta2*-nicotinic acetylcholine receptor availability and relationships to the dopaminergic system and functional connectivity in tobacco smokers.
    6. Measuring the neuroimmune state of the brain in individuals with opioid use disorder during early recovery.

    Medical Research Interests

    Alcohol Drinking; alpha7 Nicotinic Acetylcholine Receptor; Brain; Chemicals and Drugs; Diseases; Neurobiology; Neuroimaging; Nicotine; Opioid-Related Disorders; Positron-Emission Tomography; Psychiatry and Psychology; Radiology

    Research at a Glance

    Yale Co-Authors

    Frequent collaborators of Kelly Cosgrove's published research.

    Publications

    2024

    2023

    Clinical Trials

    Current Trials

    Get In Touch

    Contacts

    Mailing Address

    Psychiatry

    40 Temple

    New Haven, CT 06511-

    United States

    Locations

    • Temple Medical Center

      Academic Office

      40 Temple Street, Ste 7C

      New Haven, CT 06510